Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
39.63 EUR | 0.00% | +3.24% | -14.77% |
Jun. 10 | ABL Bio, BMS Collaborate on Gastric Cancer Treatment Trial | MT |
Jun. 07 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
Sales 2024 * | 46.09B 42.8B | Sales 2025 * | 46.06B 42.77B | Capitalization | 86.29B 80.13B |
---|---|---|---|---|---|
Net income 2024 * | -5.41B -5.03B | Net income 2025 * | 10.22B 9.49B | EV / Sales 2024 * | 2.72 x |
Net Debt 2024 * | 39.03B 36.25B | Net Debt 2025 * | 31.68B 29.42B | EV / Sales 2025 * | 2.56 x |
P/E ratio 2024 * |
-16.2
x | P/E ratio 2025 * |
8.05
x | Employees | - |
Yield 2024 * |
5.65% | Yield 2025 * |
5.93% | Free-Float | 69.27% |
Latest transcript on Bristol-Myers Squibb Company
1 week | +3.24% | ||
Current month | +4.98% | ||
1 month | -4.87% | ||
3 months | -19.53% | ||
6 months | -15.23% | ||
Current year | -14.77% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 15-01-31 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 19-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 19-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 16-03-31 |
Derica Rice
BRD | Director/Board Member | 59 | 20-08-31 |
Date | Price | Change |
---|---|---|
24-06-11 | 39.63 | 0.00% |
24-06-10 | 39.63 | +3.32% |
24-06-07 | 38.36 | +1.86% |
24-06-06 | 37.66 | -0.70% |
24-06-05 | 37.92 | -1.21% |
Real-time BOERSE MUENCHEN, June 11, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+18.87% | 249B | |
-1.96% | 216B | |
+11.11% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- BMY Stock
- BRM Stock